In a number of cases, information in advertisements did not correspond to the official characteristics of medicines, was not supported by scientific studies or references to verified sources, and contained unproven claims about the properties of medicines. This indicates the difficulty in providing accurate and balanced information to both the general public and medical professionals.
Against this background, the authorities propose to update the rules governing the regulation of drug advertising. The new rules should make the requirements clearer, especially on the Internet and social networks, distinguish between advertising and educational materials, strengthen the scientific validity of information and more clearly separate the rules for the public and for medical professionals. It is also planned to increase the transparency of inspection and control procedures and extend the timeframe for reviewing materials to improve the quality of regulation and bring the system in line with European standards.
The draft regulation on the approval of the Regulation on Ethical Promotion of Medicines, developed by the Ministry of Health and the Agency for Medicines and Medical Devices, is to be approved by the government.
